Skip to Main Content
Don't have an account? Create Account
Don't have an account? Create Account

Recall of Products Linked to B. cepacia Expanded

PharmaTech, a manufacturer of liquid docusate products, has expanded a voluntary recall of its products after an outbreak of Burkholderia cepacia (B. cepacia) infections.

The bacteria, a threat to individuals with weakened immune systems or chronic lung diseases, has been linked to a five-state outbreak.

In a July 16 announcement, the U.S. Food and Drug Administration (FDA) said PharmaTech, of Davie, Fla., voluntarily recalled all non-expired lots of Diocto Liquid, a docusate sodium solution distributed by Rugby Laboratories.

In an Aug. 9 alert, the FDA notified health care providers and consumers that the voluntary recall now applies to all of PharmaTech’s liquid products. The products are labeled by six firms: Bayshore, Centurion, Major, Metron, Rugby, and Virtus.

FDA said health care facilities, pharmacies, and consumers should stop using the products immediately.

Contact Director of Policy Erin O’Malley at or 202.585.0127 with questions.



About the Author

Michelle Rosenfeld is manager of communications at America's Essential Hospitals.

Previous Next
Test Caption
Test Description goes like this